Online Inductive Electrospray Ionization Mass Spectrometry as a

Subscriber access provided by UNIV OF CONNECTICUT

Full Paper

On-line Inductive Electrospray Ionization Mass Spectrometry as a Process Analytical Technology Tool to Monitor the Synthetic Route to Anagliptin Xin Yan, Ryan M Bain, Yafeng Li, Ran Qiu, Tawnya G. Flick, and R. Graham Cooks Org. Process Res. Dev., Just Accepted Manuscript • DOI: 10.1021/acs.oprd.6b00039 • Publication Date (Web): 12 Apr 2016 Downloaded from http://pubs.acs.org on April 15, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Organic Process Research & Development is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Organic Process Research & Development

On-line Inductive Electrospray Ionization Mass Spectrometry as a Process Analytical Technology Tool to Monitor the Synthetic Route to Anagliptin Xin Yan†, Ryan M. Bain†, Yafeng Li†, Ran Qiu†, Tawnya G. Flick*‡, R. Graham Cooks*† † Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47907, United States ‡ Department of Analytical Research & Development, Amgen Inc., 1 Amgen Center Dr, Thousand Oaks, CA 91320, United States

1 ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 21

Table of Contents Graphic


Page 3 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


ABSTRACT: Inductive electrospray ionization (iESI) is an ambient ionization method that is particularly well suited to online reaction monitoring. It allows the potential of electrospray mass spectrometry (MS) to be realized as a routine process analytical technology (PAT) tool to monitor practical synthetic reactions in real time. In this study, a synthetic route to Anagliptin (target API) was successfully monitored using on-line iESI-MS. Starting materials not seen by traditional reaction monitoring tools (HPLC-UV/Vis and GC-FID) were observed as well as water sensitive reagents and intermediates which cannot easily be followed by other methods. On-line tandem mass spectrometry (MS/MS) was used to characterize chemical species in the reaction mixture. Impurities and byproduct were identified and information on the progress of byproduct formation enabled implementation of strategies to eliminate these byproducts in the course of the reaction. This work demonstrates how iESI-MS can be employed to obtain comprehensive information and solutions to some practical problems that occur in small molecule synthetic reaction monitoring. Key words: Ambient Ionization • Spray-based Ionization • Reaction Mechanism • Chemical Synthesis • Bulk Reaction



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 21

INTRODUCTION Process analytical technology (PAT) methodology, as endorsed by the U.S. Food and Drug Administration (FDA)1,2, is a system of analytical techniques for real-time process characterization in the pharmaceutical industry which is applied increasingly in pharmaceutical development, scale-up, and manufacture.3-7 The PAT concept is embraced in the FDA’s Qualityby-Design (QbD) framework8-10 which aims at process understanding and control so that product quality is built into the manufacturing process.11 Such processes can produce consistent quality products, making product quality control less dependent on analytical testing at the endpoint, i.e. the final active pharmaceutical ingredient (API).12-14 This initiative has encouraged the pharmaceutical industry to increase research and use of new analytical technologies to perform timely measurements on critical quality attributes of raw materials, intermediates and products.1517

Successful implementation of PAT requires the appropriate selection of process analytical methods, the particulars of which depend on the application and molecule. In the FDA’s PAT definition1,11 (“a system for designing, analyzing, and controlling manufacturing through timely measurements (i.e., during processing) of critical quality and performance attributes of raw and in-process materials and processes, with the goal of ensuring final product quality”), “analyzing” equates to the use of in situ analytical tools. A variety of analytical methods have been incorporated into the PAT toolbox for on-line process monitoring, including focused beam reflectance measurement (FBRM)18-20, particle video microscopy (PVM)18,19, infrared (IR) spectroscopy11,21-28, UV/Vis spectroscopy20, Raman spectroscopy22,29,30, nuclear magnetic resonance (NMR) spectroscopy21,22,31 and high-performance liquid chromatography (HPLC)31. However, little information is provided on chemical structures by many of these measurements


Page 5 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


which only give signals for characteristic functional groups, and this remains one of the barriers to the application of spectroscopy in PAT applications. On the other hand, just as there is no single off-line analytical tool that meets all needs for process development, understanding or control strategy for any particular product, there is no single in situ analytical tool that will work for all applications. New analytical technologies need to be developed and added to the PAT toolbox. Because of its inherent sensitivity, speed, and molecular selectivity32-37, mass spectrometry (MS) has seen some use in process analysis, including in-process monitoring of exhaust gases of fermentation processes38, real-time deuterium abundance measurements in water vapor39, analysis of trace gases in food products and environmental monitoring.40,41 However, MS has not been used as a routine PAT tool to monitor reactions in real time.42-44 Recent studies have shown that a particular version of electrospray mass spectrometry, namely inductive electrospray ionization mass spectrometry (iESI-MS)45,46, can be used to continuously monitor reacting systems in a preparation-free on-line process. This analysis tool applies to organic chemical reactions and allows the study of reaction progress.47 This method has the notable advantage of being applicable to concentrated solutions of the type encountered in pharmaceutical manufacturing. An early version of such a system (Figure S1) was used to automatically sample reaction mixtures in-situ and deliver them to the MS inlet, thereby enabling the continuous reaction mixture monitoring and providing virtually real-time structural information on the intermediates and products in the mixture. Three important reactions in pharmaceutical synthesis of different types including reductive amination, Negishi crosscoupling (an air and moisture-sensitive reaction) and Pd/C-catalyzed hydrogenolysis (a heterogeneous reaction) were successfully monitored.47 This system enabled short-lived intermediates to be observed, and tracked through the synthetic reaction. The development of



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 21

iESI-MS gave opportunities for on-line MS as a PAT tool in reaction monitoring. In the course of developing the system further to allow process analysis, the Anagliptin synthetic route (target API 1, Scheme 1)48 was monitored using on-line iESI-MS. Solutions to practical problems which occurred in this realistic application were provided mainly by using additional capabilities of the mass spectrometer. Note that neither of the starting materials 2 or 3 can be detected by traditional reaction monitoring tools such as HPLC-UV/Vis and GC-FID. Also water sensitive reagents and intermediates are involved which cannot readily be followed by regular ESI-MS. Scheme 1. Synthetic route to API Anagliptin O Cl

CN

O

N

O

N H 3 C9H20N2O2 Mol. wt. 188.27

2 C7H9ClN2O Mol. wt. 172.61

H N

4N HCl / dioxane H2N

7, CDI C7H6N4O OH Mol. wt. 162.15

N N N

THF, rt 6

C8H7N3O2 Mol. wt. 177.16

HN

acetone

N

CN N

CN

O Et3N, THF

N

N H N N

N N N

N H

4 C16H28N4O3 Mol. wt. 324.43

O

N

N

O

O

H N

N

N

N O

O

5 C11H20N4O Mol. wt. 224.31

O

O

NaI, K2CO3, NH2

HN N

8 C11H9N5O Mol. wt. 227.23

N 9

H N

O

CN N

Anagliptin (1) C19H25N7O2 Mol. wt. 383.46

N 9 C3H4N2 Mol. wt. 68.08

RESULTS AND DISCUSSION Monitoring of Amidation of (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile 2, with (2Amino-2-methyl-propyl)-carbamic acid tert-butyl ester 3. The first step in the synthesis of Anagliptin, amidation of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile 2, with (2-amino-2-


Page 7 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


methyl-propyl)-carbamic acid tert-butyl ester 3 (Scheme 1), leading to the intermediate product 4 was monitored by on-line iESI-MS. The reagent 3 was first mixed with sodium iodide and potassium carbonate in acetone. The reagent 2 was then added dropwise to an ice-cooled acetone suspension and the reaction mixture was stirred at room temperature for 10 h. Time-resolved mass spectra (Figure 1) were recorded to show the progress of the reaction with designation of the detected ions, each time point requiring 1.8 seconds (average 9 scans). Figure 1a was collected before the addition of reagent 2. Sodium adducts of the reagent 3 and its dimer were detected at m/z 211 and 399. Ions at m/z 311 and 499 are assigned as the sodium adduct of dicarbamate 10 (Scheme 2) and the cluster ion of [M3+ M10+Na]+. Dicarbamate 10 arises from impurities in reagent 3 as shown by MS/MS (Figure S2). After the addition of reagent 2, the abundance of the ions at m/z 211 increased (Figure 1b), due to a contribution by the isobaric potassium adduct of reagent 2; that is, the ions of sodiated 3 overlap in nominal mass with potassiated 2 at m/z 211. This mass overlap was confirmed by the change of their

13

C isotopic distributions (Figure S3). The proportion of each

species was calculated from the experimentally observed isotopic pattern. With time, the signal due to product ion 4, observed at m/z 363 [M4+K]+ increased and it became dominant after 3 h (Figure 1d). The formation of dimers of product 4 at m/z 671 [2M4+Na]+ and m/z 687 [2M4+K]+ was also observed. The spectra then showed no significant changes out to 8 h (Figure 1f). Halogen exchange proceeded readily as was indicated by the formation of sodiated and potassiated ions of activated iodide intermediate 11 at m/z 287 and m/z 303 (Figure 1b,c,S6). The progression of the reaction is shown in Figure 2, which displays the changing abundance (normalized) of the ions corresponding to the reagent 3, intermediate 11 and the product 4. The product 4 was isolated and purified by column chromatography. The mass spectrum of 4 after



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 21

purification is shown in Figure S4a and its identity was evident from its MS/MS product ion spectrum (Figure S4b,c,d; tandem MS of 4 and its dimer in solution were shown in Figure S12). This reaction was also monitored by traditional off-line nanoelectrospray ionization (nESI) MS. The time resolved mass spectra (Figure S5) show the formation of product 4 and impurity 12 (discuss later), but the ions of reagent 2 and 3 were suppressed by the strong signal from the protonated acetone dimer at m/z 117 and thus could not be followed. The fact that more species were ionized well in online-iESI makes this monitoring system an effective tool to follow the reactions.

Figure 1. Time-resolved mass spectra of amidation of (R)-1-(2-chloroacetyl)pyrrolidine-2carbonitrile 2 with (2-amino-2-methyl-propyl)-carbamic acid tert-butyl ester 3 by iESI-MS.


Page 9 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Scheme 2. Structures and molecular masses of impurities 10, active intermediate 11 and byproduct 12, 13 in the synthetic route to Anagliptin 1 NC N O

O O

N H

O

H N

O O

10 C14 H28N2 O4 Mol. wt.288.39

I

N

11 C7H9IN2O Mol. wt. 264.07

O

O

CN O

O N H

N

CN N

12 C23H36N6O4 Mol. wt. 460.58

N N

N H

H N

O

CN N

13 C15H22N6O2 Mol. Wt.318.38

Figure 2. Reaction progress of the amidation of (R)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile 2 with (2-amino-2-methyl-propyl)-carbamic acid tert-butyl ester 3. Average total ion intensity is around 8E5.

Ions at m/z 499 were observed before the addition of reagent 2 and the ions are assigned from the MS/MS data (Figure 3a,b) as corresponding to the sodium binding adduct of 10 and 3. The dicarbamate 10 also reacted with excess reagent 2 to form the product 4, resulting in the decreasing abundance of the ions at m/z 499 with full disappearance occurring within 2 h. However, the signal intensity at m/z 499 started to increase again at 5 h and reached 7% of the base peak at 8 h. This latter species was identified as the product 12 of a second amidation of 4 with reagent 2 and its identity was confirmed by the different tandem mass spectrum from that of the earlier species (Figure 3c,d). The MS spectrum of the latter species 12 after purification was 9 ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 21

in agreement with this assignment (Figure S7). These results demonstrate the advantage of using MS as a PAT tool to monitor low-level impurities that are formed and tracked through the synthetic reaction mixture.

Figure 3. Tandem MS spectra of ions at (a) m/z 499 and (b) ions formed before the addition of reagent 2; (c)and (d) show MS3 spectra of ions formed after 5 h.

Another phenomenon worthy of note is the presence of both sodium adducts and potassium adducts of the same species. Both sodiated or potassiated ions are readily formed in the presence of sodium iodide and potassium carbonate in the reaction mixture. They include m/z 211 [M3+Na]+, 227 [M3+K]+; 287 [M11+Na]+, 303 [M11+K]+; 311 [M12+Na]+, 327 [M12+K]+ and 347 [M4+Na]+, 363 [M4+K]+ (Figure 1, S11), and their formation is competitive. The concentration of K+ is twice than that of Na+, however, all the ions formed are sodium adducts (Figure 1a,b) at the beginning of the reaction. This shows that potassium competes less well than sodium in adduct formation with this suite of compounds. As the reaction went on, the disappearance of sodiated ions and formation of potassiated ions for all these three species in the reaction mixture 10 ACS Paragon Plus Environment

Page 11 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


was observed. This is consistent with the preferential removal of sodium ions as an insoluble (in acetone) precipitate of sodium chloride.49

Monitoring the Deprotection of Compound 4. In step 2 (Scheme 1) of the synthetic route to Anagliptin, the reaction of 4 with 4 N hydrochloric acid in 1,4-dioxane and dichloromethane, deprotects the Boc group. The reaction mixture was analyzed after dilution with the reaction solvent, 1,4-dioxane and dichloromethane (1:1, v:v). The time-resolved mass spectra (Figure 4) show the progress of the reaction. Figure 4a was recorded 1 min after the addition of 4 N hydrochloric acid in 1,4-dioxane. Protonated 4 and its dimer were detected at m/z 325 and 649, respectively. Meanwhile, a new ionic species at m/z 223 had started to be observed. In subsequent reaction monitoring MS spectra (representative spectra shown at 10 min, 20 min and 50 min, Figure 4b-d), showed ions of protonated 4 and its dimers decreasing in abundance, while ions at m/z 223 continually increased and eventually dominated the spectra after 50 min. This latter signal represents the major product of this reaction.



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 21

Figure 4. Time-resolved mass spectra of reaction of 4 with 4 N hydrochloric acid in 1,4-dioxane and dichloromethane by iESI-MS.

The observed cations at m/z 223 are designated as [M5 - H]+, loss of hydride from the neutral molecules with its MS/MS shown in Figure S8b. The key step in ESI is normally the generation of the protonated form of the molecule: M + AH+ [M+H]+ + A. However, hydride abstraction is a well-known route to positive ion formation in chemical ionization (CI) MS. Factors such as the composition of the reaction mixture are known44 to affect the outcome of the competition between a proton donotion and hydride loss. In order to confirm the species at m/z 223, methanol was used as dilution solvent before analysis of the reaction mixture. Ions at m/z 223 moved to m/z 225 while other major ions in the solution remained unaffected (Figure S8a, c). The ions at m/z 225 were assigned to [M5+H]+ based on their fragmentation (Figure S8d).

Monitoring of Formation of Anagliptin 1. The third step in the synthetic route to Anagliptin includes two reactions which occur sequentially without separation of intermediates: activation of 2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid 6 with N, N’-carbonyldiimidazole (CDI) 7 to yield the corresponding acylimidazole 8, followed by amination with (S)-1-((1-amino-2methylpropan-2-yl)glycyl)pyrrolidine-2-carbonitrile 5, leading to the final product, Anagliptin 1 (Scheme 1). CDI 7 was first added to a solution of 6 in tetrahydrofuran (THF), and the mixture was stirred at room temperature. Figures S9a,b show spectra recorded before the addition of CDI 7. Reagent 6 is poorly protonated in the positive ion mode (Figure S9a), while it is easily deprotonated in the negative ion mode due to the carboxyl group (Figure S9b). Considering that other major ionic species involved in this reaction step will likely be observed as the protonated molecules, the


Page 13 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


positive ion mode was used as the ionization mode of choice when monitoring the reaction, but the negative ion mode offered complementary information. After adding CDI 7 to the reaction solution, protonated imidazole and its dimer were rapidly destroyed due to the sensitivity of CDI 7 to water. Protected by the use of a N2 sheath gas in online-iESI, the protonated CDI 7 at m/z 163 could still be seen with low intensity in the spectra (Figure 5a). The activated carboxylic acid product 8 is also water sensitive, while protonated 8 was detected at m/z 288 and confirmed by MS/MS (Figure 5d). The comparison experiment was done using traditional nESI-MS with CDI 7 in anhydrous THF (Figure 5b) and then reaction with 6 (Figure 5c). Neither protonated CDI 7 nor product 8 could be detected in the traditional nESI-MS. The current iESI reaction monitoring system is well suited to follow moisture sensitive reactions which are commonly applied in the pharmaceutical industry.

Figure 5. MS spectra of activation of 2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid 6 with N, N’-carbonyldiimidazole (CDI) 7 in THF analyzed by (a) online iESI-MS (b,c) traditional



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 14 of 21

nESI. Note, (b) is the mass spectrum of pure CDI 7 in THF. (c,d) tandem MS of acylimidazole (8).

The reaction mixture was added dropwise to 5 in an ice-cooled solution of triethylamine in THF in order to form the product 1. The mixture was warmed to room temperature and stirred. The spectrum shown in Figure 6a was recorded before adding the reaction mixture. Protonated 5, its dimer, water cluster and triethylamine cluster were detected separately at m/z 225, 449, 243 and 326, respectively. New ionic species at m/z 543 and 319 were seen right after the reaction mixture containing the acylimidazole was added dropwise to the solution (Figure 6b,c). Ions at m/z 319 are assigned to protonated 13 (Scheme 2) based on MS/MS data (Figure S10c,d). The major byproduct 13, originates from the side reaction of amine 5 with CDI 7, and the ions at m/z 543 are ionic clusters of 5 with protonated 13 (Figure S10a). The purity of commercial CDI 7 may be variable due to its water sensitivity, therefore it is common to employ excess in the activation step to ensure complete conversion of the carboxylic acid to the acylimidazole. The unreacted CDI 7 also reacted with the amine 5. From the reaction monitoring data, the amine 5 was shown to react faster with residual CDI 7 than with the acylimidazole 8 (Figure 6b, c). Once the byproduct formed, its signal remained relatively constant. This suggests the byproduct cannot be avoided by stopping the reaction early, instead reducing the amount of CDI 7 in the previous step can decrease the byproduct formation. After the reaction was allowed to occur for 30 mins, the product ions, protonated Anagliptin 1 at m/z 384, started to form and reached its maximum at the end of the reaction period (Figure 6d,e,f). The structure of the product 1 was confirmed by MS/MS (Figure S10b). The other product, the imidazole 9, was observed at m/z 69. The reported yield45 of this step is only 33% without corrections for impurities formed. The information on impurities generated in this reaction was provided from the above experiment.


Page 15 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figure 6. Time-resolved mass spectra of amidation of (R)-1-(2-chloroacetyl)pyrrolidine-2carbonitrile 6 with (2-amino-2-methyl-propyl)-carbamic acid tert-butyl ester 5 by iESI-MS.

CONCLUSION The iESI-MS was investigated as a useful PAT tool on monitoring the synthetic route of Anagliptin in real time. The chemical species involved in the reactions were identified using MS/MS data. Active intermediates, impurities and byproducts were identified in the reaction mixture. Two pairs of ions with the same m/z were differentiated based on isotopic distribution and tandem MS and their structures were assigned. Moreover, the current iESI-MS reaction monitoring system shows advantages in better ionization of species in the reaction mixture compared with the analysis using traditional nESI-MS. It also shows the capability to monitor water sensitive reagents and intermediates. The formation of byproducts due to the excess water15 ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 16 of 21

sensitive reagent were followed, and its reaction rate was found to be much faster than that of the target reaction. The work provides a comprehensive demonstration of process monitoring by mass spectrometry including solutions to some practical problems that occur in small molecule synthetic reaction monitoring. The probe used for this analysis could also be used to monitor reactions at different scales.

EXPERIMENTAL SECTION Instrumentation. A linear ion trap mass spectrometer (LTQ, Thermo Fisher Scientific, San Jose, CA, USA) was used to record positive ion mode full scan mass and MSn spectra. Typical MS parameters included averaging of 3 microscans, 100 ms maximum injection time, 15 V capillary voltage, 150°C capillary temperature, and 65 V tube lens voltage. Data were acquired and processed using Xcalibur 2.0 software (Thermo Fisher Scientific). The identification of analyte ions was confirmed by tandem mass spectrometry (MS/MS) using collision-induced dissociation (CID). An isolation window of 1.5 Th (mass/charge units) and normalized collision energy of 30 % – 40 % (manufacturer’s unit) were selected for the CID experiments. Chemicals and Reagents. All reagents and solvents were used directly without any further purification. (2-Amino-2-methyl-propyl)-carbamic acid tert-butyl ester 3 was purchased from J&W Pharmlab, LLC; (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile 2 was purchased from Alchem Pharmtech. 2-Methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid 6 was purchased from Advanced ChemBlocks Inc; N, N’-carbonyldiimidazole 7, sodium iodide, potassium carbonate, acetone were purchased from Sigma-Aldrich (St. Louis, MO, USA). OmniSolv HPLC grade methanol was purchased from EMD (Bedford, MA, USA). Water was purified and deionized using a Milli-Q system (Millipore, Bedford, MA, USA). 16 ACS Paragon Plus Environment

Page 17 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Synthesis

of

(S)-t-butyl

(2-((2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-

methylpropyl)carbamate (4). A solution of (S)-1-(2-chloroacetyl) pyrrolidine-2-carbonitrile 2 (3 mmol, 673.4 mg) in acetone (6 ml) was added to an ice-cooled stirred suspension of (2-amino2-methyl-propyl)-carbamic acid tert-butyl ester (3 mmol, 565 mg) 3, NaI (3.9 mmol, 584.8 mg), and K2CO3 (3.9 mmol, 539.2 mg) in acetone (14 ml). The reaction mixture was stirred at room temperature for 10 h. The resulting mixture was filtered to remove insoluble materials, and concentrated under reduced pressure. The residue was purified by column chromatography on silica

gel

to

give

(S)-t-butyl

(2-((2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-

methylpropyl)carbamate (4). Synthesis of (2-amino-2-methyl-propyl)-carbamic acid tert-butyl ester (5). (2-((2-(2Cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)carbamate

4

(210.3

mg)

in

dichloromethane (40 ml) was added to 4 N hydrochloric acid/1,4-dioxane (40 ml) and the mixture was stirred at room temperature until reaction was complete in 1 hour. The product was concentrated under reduced pressure to give 5. Synthesis of (S)-N-(2-((2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2methylpyrazolo[1,5-a]pyrimidine-6-carboxamide (1). Carbonyl diimidazole 7 (17.8 mg, 0.11 mmol) was added to a solution of 6 (17.7 mg, 0.1 mmol) in tetrahydrofuran (5.7 mL), and the mixture was stirred at room temperature for 4 h. The reaction mixture was slowly added to 5 (29.7 mg, 0.1 mmol) in an ice-cooled solution of triethylamine (69 uL) in tetrahydrofuran (5.7 mL). The mixture was warmed to room temperature and stirred until reaction completion. The reaction mixture was concentrated under reduced pressure, and then dichloromethane was added to the residue. Insoluble materials were removed by filtration and the filtrate was concentrated



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 18 of 21

under reduced pressure. The residue was subjected to column chromatography (eluting solvent; dichloromethane/methanol, 50:1) to yield pure 1 (30%).

ASSOCIATED CONTENT Supporting information Additional information as noted in text.

AUTHOR INFORMATION Corresponding Author *Flick G. Tawnya E-mail: [email protected] *R. Graham Cooks E-mail: [email protected] Notes The authors declare no competing financial interest.

ACKNOWLEDGMENTS Authors acknowledge funding support from Amgen Inc. and the National Science Foundation (CHE-1307264) as well as contributions of Dr. Laura Blue and Dr. Yuan-Qing Fang.


Page 19 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


REFERENCES (1)

Guidance for Industry:

PAT  A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, 2004. (2) Chew, W.; Sharratt, P. Trends in process analytical technology. Analytical Methods 2010, 2, 1412-1438. (3) Chanda, A.; Daly, A. M.; Foley, D. A.; LaPack, M. A.; Mukherjee, S.; Orr, J. D.; Reid, G. L.; Thompson, D. R.; Ward, H. W. Industry Perspectives on Process Analytical Technology: Tools and Applications in API Development. Org. Process Res. Dev. 2015, 19, 63-83. (4) Schaefer, C.; Clicq, D.; Lecomte, C.; Merschaert, A.; Norrant, E.; Fotiad, F. A Process Analytical Technology (PAT) approach to control a new API manufacturing process: Development, validation and implementation. Talanta 2014, 120, 114-125. (5) Pomerantsev, A. L.; Rodionova, O. Y. Process analytical technology: a critical view of the chemometricians. J. Chemometr. 2012, 26, 299-310. (6) Rodrigues, L. O.; Alves, T. P.; Cardoso, J. P.; Menezes, J. C. Improving drug manufacturing with process analytical technology. IDrugs 2006, 9, 44-48. (7) Sever, N. E.; Warman, M.; Mackey, S.; Dziki, W.; Jiang, M. Process Analytical Technology in Solid Dosage Development and Manufacturing. Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice 2009, 827-841. (8) Liu, D. Q.; Chen, T. K.; McGuire, M. A.; Kord, A. S. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process. Journal of Pharmaceutical and Biomedical Analysis 2009, 50, 144-150. (9) Riley, B. S.; Li, X. H. Quality by Design and Process Analytical Technology for Sterile Products-Where Are We Now? AAPS PharmSciTech 2011, 12, 114-118. (10) Wu, H. Q.; White, M.; Khan, M. A. Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. Int. J. Pharm. 2011, 405, 63-78. (11) El-Hagrasy, A. S.; Drennen, J. K. A Process Analytical Technology approach to nearinfrared process control of pharmaceutical powder blending. Part III: Quantitative near-infrared calibration for prediction of blend homogeneity and characterization of powder mixing kinetics. Journal of Pharmaceutical Sciences 2006, 95, 422-434. (12) Saleemi, A. N.; Steele, G.; Pedge, N. I.; Freeman, A.; Nagy, Z. K. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy. Int. J. Pharm. 2012, 430, 56-64. (13) Kourti, T. Process analytical technology beyond real-time analyzers: The role of multivariate analysis. Crit. Rev. Anal. Chem. 2006, 36, 257-278. (14) Patel, S. M.; Pikal, M. Process Analytical Technologies (PAT) in freeze-drying of parenteral products. Pharm. Dev. Technol. 2009, 14, 567-587. (15) Wu, H. Q.; Khan, M. THz spectroscopy: An emerging technology for pharmaceutical development and pharmaceutical Process Analytical Technology (PAT) applications. J. Mol. Struct. 2012, 1020, 112-120. (16) Streefland, M.; Martens, D. E.; Beuvery, E. C.; Wijffels, R. H. Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production. Eng. Life Sci. 2013, 13, 212-223. 19 ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 20 of 21

(17) Rathore, A. S.; Bhambure, R.; Ghare, V. Process analytical technology (PAT) for biopharmaceutical products. Analytical and Bioanalytical Chemistry 2010, 398, 137-154. (18) Liu, X.; Sun, D.; Wang, F.; Wu, Y.; Chen, Y.; Wang, L. Monitoring of Antisolvent Crystallization of Sodium Scutellarein by Combined FBRM–PVM–NIR. Journal of Pharmaceutical Sciences 2011, 100, 2452-2459. (19) Sistare, F.; Berry, L. S. P.; Mojica, C. A. Process analytical technology: An investment in process knowledge. Org. Process Res. Dev. 2005, 9, 332-336. (20) Simone, E.; Zhang, W.; Nagy, Z. K. Application of Process Analytical Technology-Based Feedback Control Strategies To Improve Purity and Size Distribution in Biopharmaceutical Crystallization. Cryst. Growth Des. 2015, 15, 2908-2919. (21) Drexler, M. T.; Foley, D. A.; Ward, H. W., II; Clarke, H. J. IR and NMR Reaction Monitoring Techniques for Nucleophilic Addition Reactions: In Situ Monitoring of the Addition of Benzimidazole to a Pyridinium Salt. Org. Process Res. Dev. 2015, 19, 1119-1127. (22) Schaefer, C.; Lecomte, C.; Clicq, D.; Merschaert, A.; Norrant, E.; Fotiadu, F. On-line near infrared spectroscopy as a Process Analytical Technology (PAT) tool to control an industrial seeded API crystallization. Journal of Pharmaceutical and Biomedical Analysis 2013, 83, 194-201. (23) Druy, M. A. Applications for mid-IR spectroscopy in the pharmaceutical process environment - Mid-IR continues to prove its usefulness as a process analytical technology. Spectroscopy 2004, 19, 60-63. (24) Cogdill, R. P.; Anderson, C. A.; Drennen, J. K., 3rd. Process analytical technology case study, part III: calibration monitoring and transfer. AAPS PharmSciTech 2005, 6, E284-297. (25) Cogdill, R. P.; Anderson, C. A.; Delgado, M.; Chisholm, R.; Bolton, R.; Herkert, T.; Afnan, A. M.; Drennen, J. K., 3rd. Process analytical technology case study: part II. Development and validation of quantitative near-infrared calibrations in support of a process analytical technology application for realtime release. AAPS PharmSciTech 2005, 6, E273-283. (26) Swarbrick, B. Process analytical technology: A strategy for keeping manufacturing viable in Australia. Vibrational Spectroscopy 2007, 44, 171-178. (27) Sulub, Y.; LoBrutto, R.; Vivilecchia, R.; Wabuyele, B. W. Content uniformity determination of pharmaceutical tablets using five near-infrared reflectance spectrometers: A process analytical technology (PAT) approach using robust multivariate calibration transfer algorithms. Analytica Chimica Acta 2008, 611, 143-150. (28) Moes, J. J.; Ruijken, M. M.; Gout, E.; Frijlink, H. W.; Ugwoke, M. I. Application of process analytical technology in tablet process development using NIR spectroscopy: Blend uniformity, content uniformity and coating thickness measurements. Int. J. Pharm. 2008, 357, 108-118. (29) Clegg, I. M.; Pearce, J.; Content, S. In Situ Raman Spectroscopy: A Process Analytical Technology Tool to Monitor a De-protection Reaction Carried Out in Aqueous Solution. Appl. Spectrosc. 2012, 66, 151-156. (30) Johansson, J.; Claybourn, M.; Folestad, S.: Raman Spectroscopy: A Strategic Tool in the Process Analytical Technology Toolbox. In Emerging Raman Applications and Techniques in Biomedical and Pharmaceutical Fields; Matousek, P., Morris, M. D., Eds.; Biological and Medical Physics Biomedical Engineering; Springer: New York, 2010; pp 241-262. (31) Foley, D. A.; Wang, J.; Maranzano, B.; Zell, M. T.; Marquez, B. L.; Xiang, Y. Q.; Reid, G. L. Online NMR and HPLC as a Reaction Monitoring Platform for Pharmaceutical Process Development. Anal. Chem. 2013, 85, 8928-8932. (32) Krogh, E. T.; Gill, C. G. Membrane introduction mass spectrometry (MIMS): a versatile tool for direct, real-time chemical measurements. Journal of Mass Spectrometry 2014, 49, 1205-1213.


Page 21 of 21

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


(33) Stolee, J. A.; Shrestha, B.; Mengistu, G.; Vertes, A. Observation of Subcellular Metabolite Gradients in Single Cells by Laser Ablation Electrospray Ionization Mass Spectrometry. Angewandte Chemie International Edition 2012, 51, 10386-10389. (34) Spooner, N.; Lad, R.; Barfield, M. Dried Blood Spots as a Sample Collection Technique for the Determination of Pharmacokinetics in Clinical Studies: Considerations for the Validation of a Quantitative Bioanalytical Method. Anal. Chem. 2009, 81, 1557-1563. (35) Chai, Y.; Jiang, K.; Pan, Y. Hydride transfer reactions via ion–neutral complex: fragmentation of protonated N-benzylpiperidines and protonated N-benzylpiperazines in mass spectrometry. Journal of Mass Spectrometry 2010, 45, 496-503. (36) Wu, Y.; Wang, F.; Liu, Z.; Qin, H.; Song, C.; Huang, J.; Bian, Y.; Wei, X.; Dong, J.; Zou, H. Five-plex isotope dimethyl labeling for quantitative proteomics. Chemical Communications 2014, 50, 1708-1710. (37) Zheng, Q.; Liu, Y.; Chen, Q.; Hu, M.; Helmy, R.; Sherer, E. C.; Welch, C. J.; Chen, H. Capture of Reactive Monophosphine-Ligated Palladium(0) Intermediates by Mass Spectrometry. Journal of the American Chemical Society 2015, 137, 14035-14038. (38) Chauvatcharin, S.; Seki, T.; Fujiyama, K.; Yoshida, T. ONLINE MONITORING AND CONTROL OF ACETONE-BUTANOL FERMENTATION BY MEMBRANE-SENSOR MASS-SPECTROMETRY. Journal of Fermentation and Bioengineering 1995, 79, 264-269. (39) Smith, D.; Spanel, P. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. Mass Spectrometry Reviews 2005, 24, 661-700. (40) Heinzle, E.; Oeggerli, A.; Dettwiler, B. On-line fermentation gas analysis: Error analysis and application of mass spectrometry. Analytica Chimica Acta 1990, 238, 101-115. (41) Erni, F. LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY IN THE PHARMACEUTICALINDUSTRY - OBJECTIVES AND NEEDS. Journal of Chromatography 1982, 251, 141-151. (42) Vikse, K. L.; Ahmadi, Z.; Luo, J.; van der Wal, N.; Daze, K.; Taylor, N.; McIndoe, J. S. Pressurized sample infusion: An easily calibrated, low volume pumping system for ESI-MS analysis of reactions. International Journal of Mass Spectrometry 2012, 323–324, 8-13. (43) Vikse, K. L.; Woods, M. P.; McIndoe, J. S. Pressurized Sample Infusion for the Continuous Analysis of Air- And Moisture-Sensitive Reactions Using Electrospray Ionization Mass Spectrometry. Organometallics 2010, 29, 6615-6618. (44) Clinton, R.; Creaser, C. S.; Bryant, D. Real-time monitoring of a pharmaceutical process reaction using a membrane interface combined with atmospheric pressure chemical ionisation mass spectrometry. Analytica Chimica Acta 2005, 539, 133-140. (45) Huang, G.; Li, G.; Ducan, J.; Ouyang, Z.; Cooks, R. G. Synchronized Inductive Desorption Electrospray Ionization Mass Spectrometry. Angew. Chem.-Int. Edit. 2011, 50, 2503-2506. (46) Huang, G.; Li, G.; Cooks, R. G. Induced Nanoelectrospray Ionization for Matrix-Tolerant and High-Throughput Mass Spectrometry. Angew. Chem.-Int. Edit. 2011, 50, 9907-9910. (47) Yan, X.; Sokol, E.; Li, X.; Li, G.; Xu, S.; Cooks, R. G. On-Line Reaction Monitoring and Mechanistic Studies by Mass Spectrometry: Negishi Cross-Coupling, Hydrogenolysis, and Reductive Amination. Angew. Chem.-Int. Edit. 2014, 53, 5931-5935. (48) Kato, N.; Oka, M.; Murase, T.; Yoshida, M.; Sakairi, M.; Yakufu, M.; Yamashita, S.; Yasuda, Y.; Yoshikawa, A.; Hayashi, Y.; Shirai, M.; Mizuno, Y.; Takeuchi, M.; Makino, M.; Takeda, M.; Kakigami, T. Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors. Organic and medicinal chemistry letters 2011, 1, 7-7. (49) Ervithayasuporn, V.; Pornsamutsin, N.; Prangyoo, P.; Sammawutthichai, K.; Jaroentomeechai, T.; Phurat, C.; Teerawatananond, T. One-pot synthesis of halogen exchanged silsesquioxanes: octakis(3-bromopropyl)octasilsesquioxane and octakis(3-iodopropyl)octasilsesquioxane. Dalton Transactions 2013, 42, 13747-13753. 21 ACS Paragon Plus Environment

Online Inductive Electrospray Ionization Mass Spectrometry as a

Recommend Documents